2016 Nov 01
Genomic Testing & Precision Medicine: Bigger Is Better
Olivier Elemento, Ph.D., and Mark Rubin, M.D., penned a guest piece in Oncology Times about genomics in oncology and the role of precision medicine Read more
2016 Oct 31
API-based genomics databank facilitates personalized medicine
Personalized medicine is getting a boost at Weill Cornell Medicine with an online genomics databank that uses an API to integrate insights into the clinical workflow. Read more
2016 Oct 28
How combining an evolutionary perspective with genomic methods can advance CLL treatment
Dan Landau, M.D., Ph.D. speaks about clonal evolution in chronic lymphocytic leukemia (CLL), after his talk at the 2016 International Workshop of the German CLL Study Group in Cologne, Germany. Read more
2016 Oct 28
Research identifies new target for cancer therapy
Epichaperomes’ that form in some cancer cells might enable selective therapies, according to research from Monica Guzman, Ph.D. Read more
2016 Oct 27
White adipose tissue inflammation in early-stage breast cancer
Inflammation of white adipose tissue may be a better predictor of breast cancer incomes than body mass index, according to Andrew Dannenberg, M.D. Read more
2016 Oct 26
Ending cancer as we know it
Rohan Ramakrishna, M.D., offers his analysis of the Cancer Moonshot Task Force recommendations. Read more
2016 Oct 25
$2M gift to drive Weill Cornell advances in immunotherapy
Ellen and Gary Davis have generously made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy. Read more
2016 Oct 24
Precision medicine is more than genomic sequencing
There has been an overemphasis on the genomic component of precision medicine, according to Mark Rubin, M.D., director of the Englander Institute for Precision Medicine. Read more
2016 Oct 21
Researchers tackle metastatic breast cancer
Linda Vahdat, M.D., appeared on CBS News to discuss her novel copper depletion therapy for metastatic breast cancer. Read more
2016 Oct 20
Apostolou receives $1.5m NIH New Innovator Award
Eftychia Apostolou, Ph.D., has won a New Innovator Award from the National Institutes of Health for her research on how cells preserve their identity under normal conditions or alter it during pathogenesis Read more
2016 Oct 20
Brain surgeon chases new therapies for hard-to-treat tumors
Rohan Ramakrishna, M.D., is testing two innovative new therapies for recurrent glioblastoma and gliosarcoma. Read more
2016 Oct 20
Furman advises in CLL: Choose appropriate agents and focus on PFS endpoint
Richard Furman, M.D., shared insights into CLL treatments at a special session of the 2016 Annual ASH Meeting on Hematologic Malignancies. Read more
2016 Oct 19
Cold caps help breast cancer patients save their hair
A CBS News feature about cold cap therapy for breast cancer includes a Weill Cornell patient and Tessa Cigler, M.D. Read more
2016 Oct 19
Cryoablation: Freezing away breast cancers
Rache Simmons, M.D., discusses a new non-surgical deep-freezing treatment for breast cancer. Read more
2016 Oct 17
Study finds what could be a key to prostate cancer progression
Mark Rubin, M.D., discusses the findings of a study of DNA-repair gene mutations in predicting invasive prostate cancer. Read more
2016 Oct 17
Chemotherapy drives treatment resistance in bladder cancer
While chemotherapy kills the most common type of bladder cancer, urothelial cancer, it also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant, according to Bishoy Faltas and colleagues. Read more
2016 Oct 10
Do I Have a Hidden Cancer?
A profile of Francis Barany, Ph.D., and some of his cancer detection tests. Read more
2016 Oct 10
Gene identified that drives aggressive prostate cancer
David Rickman, Ph.D., and colleagues have identified a gene that appears to regulate the change from prostate adenocarcinoma to neuroendocrine prostate cancer. Read more
2016 Oct 08
Alisertib may benefit certain patients with neuroendocrine prostate cancer
Alisertib monotherapy may be effective in certain patients with clinical or pathologically defined neuroendocrine prostate cancer, according to Himisha Beltran, M.D. Read more
2016 Oct 07
Chasing after ‘Compassionate Use’
Jeffrey Greenfield, M.D., Ph.D., speaks out about the need for wider - and speedier - use of the FDA compassionate use exception. Read more
